DBV Technologies (DBVT) Amortization (2015 - 2019)
DBV Technologies (DBVT) reported Amortization of $1.6 million for Q3 2019, down 43.49% on a QoQ basis from $2.8 million in Q4 2018.
DBV Technologies (DBVT) has 5 years of Amortization data on file, last reported at $1.6 million in Q3 2019.
- Quarterly Amortization changed N/A year-over-year to $1.6 million in Q3 2019, while the trailing twelve-month figure through Dec 2017 was $2.4 million (up 9.1% YoY) and the FY2018 annual result came in at $2.3 million, down 3.01% from the prior year.
- Amortization slipped to $1.6 million in Q3 2019 per DBVT's latest filing, from $2.8 million in the prior quarter.
- Across five years, Amortization topped out at $376.3 million in Q4 2015 and bottomed at $1.6 million in Q3 2019.
- The 5-year median for Amortization is $2.6 million (2017), against an average of $126.0 million.
- The widest annual swing landed in 2016, when Amortization tumbled 99.42%; it then climbed 19.14% in 2018.
- Tracing DBVT's Amortization over 5 years: stood at $376.3 million in 2015, then plunged by 99.42% to $2.2 million in 2016, then gained by 9.1% to $2.4 million in 2017, then rose by 19.14% to $2.8 million in 2018, then sank by 43.49% to $1.6 million in 2019.
- Per Business Quant, the three latest DBVT Amortization figures stand at $1.6 million (Q3 2019), $2.8 million (Q4 2018), and $2.4 million (Q4 2017).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.75 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 1.60 Mn |
| Sep 30, 2019 | 1.60 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Dec 31, 2018 | 2.83 Mn |
| Dec 31, 2017 | 2.37 Mn |
| Dec 31, 2017 | 2.37 Mn |
| Dec 31, 2016 | 2.18 Mn |
| Dec 31, 2016 | 2.18 Mn |
| Jun 30, 2016 | 370.67 Mn |
| Jun 30, 2016 | 370.67 Mn |
| Dec 31, 2015 | 376.28 Mn |
| Dec 31, 2015 | 376.28 Mn |